这是一篇来自已证抗体库的有关人类 SRC3的综述,是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合SRC3 抗体。
SRC3 同义词: ACTR; AIB-1; AIB1; CAGH16; CTG26; KAT13B; RAC3; SRC-3; SRC3; TNRC14; TNRC16; TRAM-1; bHLHe42; pCIP; nuclear receptor coactivator 3; CBP-interacting protein; amplified in breast cancer 1 protein; class E basic helix-loop-helix protein 42; receptor-associated coactivator 3; steroid receptor coactivator protein 3; thyroid hormone receptor activator molecule 1

艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 SRC3抗体(Abcam, ab2831)被用于被用于免疫印迹在人类样品上 (图 1). Mol Cells (2016) ncbi
小鼠 单克隆(AX15.3)
  • 染色质免疫沉淀 ; 人类
艾博抗(上海)贸易有限公司 SRC3抗体(Abcam, ab2782)被用于被用于染色质免疫沉淀 在人类样品上. BMC Cancer (2013) ncbi
赛默飞世尔
兔 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
  • 免疫印迹; 人类; 1:1000; 图 1
赛默飞世尔 SRC3抗体(Thermo Fisher Scientific, PA1-845)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 3) 和 被用于免疫印迹在人类样品上浓度为1:1000 (图 1). Proc Natl Acad Sci U S A (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000
赛默飞世尔 SRC3抗体(ThermoScientific, PA1-845)被用于被用于免疫印迹在人类样品上浓度为1:2000. Endocrinology (2013) ncbi
赛信通(上海)生物试剂有限公司
兔 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 2979)被用于被用于免疫印迹在人类样品上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
兔 单克隆(5E11)
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 2126)被用于被用于免疫印迹在人类样品上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
兔 单克隆(5E11)
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 5E11)被用于被用于免疫印迹在小鼠样品上 (图 3a). J Steroid Biochem Mol Biol (2017) ncbi
兔 单克隆(5E11)
  • 免疫印迹基因敲除验证; 人类; 图 4
  • 免疫沉淀; 人类; 图 4
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell signaling, 2126)被用于被用于免疫印迹基因敲除验证在人类样品上 (图 4) 和 被用于免疫沉淀在人类样品上 (图 4). Cell Rep (2016) ncbi
兔 单克隆(5E11)
  • 免疫印迹基因敲除验证; 小鼠; 图 1
  • 免疫组化-石蜡切片; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 2126)被用于被用于免疫印迹基因敲除验证在小鼠样品上 (图 1) 和 被用于免疫组化-石蜡切片在小鼠样品上 (图 1). Int J Biol Sci (2015) ncbi
兔 单克隆(5E11)
  • 免疫组化基因敲除验证; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 2126)被用于被用于免疫组化基因敲除验证在小鼠样品上 (图 1). Int J Biol Sci (2014) ncbi
兔 单克隆(5E11)
  • 免疫组化-石蜡切片; 人类; 1:75; 图 1a
  • 免疫印迹; 人类; 1:1000; 图 1d
赛信通(上海)生物试剂有限公司 SRC3抗体(Cell Signaling, 5E11)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:75 (图 1a) 和 被用于免疫印迹在人类样品上浓度为1:1000 (图 1d). Oncogene (2014) ncbi
碧迪BD
小鼠 单克隆(34/AIB-1)
  • 免疫印迹; 人类; 图 3c
碧迪BD SRC3抗体(BD, 611104)被用于被用于免疫印迹在人类样品上 (图 3c). Nat Med (2017) ncbi
小鼠 单克隆(34/AIB-1)
  • 免疫印迹; 人类
碧迪BD SRC3抗体(BD Biosciences, 611105)被用于被用于免疫印迹在人类样品上. Cell Syst (2017) ncbi
小鼠 单克隆(34/AIB-1)
  • 染色质免疫沉淀 ; 人类; 图 3g
碧迪BD SRC3抗体(BD Biosciences, 611105)被用于被用于染色质免疫沉淀 在人类样品上 (图 3g). Oncogene (2017) ncbi
小鼠 单克隆(34/AIB-1)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 s1
碧迪BD SRC3抗体(BD Biosciences, 61105)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:50 (图 s1). BMC Cancer (2016) ncbi
小鼠 单克隆(34/AIB-1)
  • 其他; 人类; 图 st1
碧迪BD SRC3抗体(BD, 34)被用于被用于其他在人类样品上 (图 st1). Mol Cell Proteomics (2016) ncbi
文章列表
  1. Zhang P, Wang D, Zhao Y, Ren S, Gao K, Ye Z, et al. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. Nat Med. 2017;23:1055-1062 pubmed 出版商
  2. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  3. Harrod A, Fulton J, Nguyen V, Periyasamy M, Ramos Garcia L, Lai C, et al. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene. 2017;36:2286-2296 pubmed 出版商
  4. You D, Zhao H, Wang Y, Jiao Y, Lu M, Yan S. Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation. Mol Cells. 2016;39:663-8 pubmed 出版商
  5. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  6. Patrick N, Griggs C, Icenogle A, Gilpatrick M, Kadiyala V, Jaime Frias R, et al. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1. J Steroid Biochem Mol Biol. 2017;167:1-13 pubmed 出版商
  7. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed 出版商
  8. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed 出版商
  9. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  10. Kyathanahalli C, Organ K, Moreci R, Anamthathmakula P, Hassan S, Caritis S, et al. Uterine endoplasmic reticulum stress-unfolded protein response regulation of gestational length is caspase-3 and -7-dependent. Proc Natl Acad Sci U S A. 2015;112:14090-5 pubmed 出版商
  11. Chen X, Qin L, Liu Z, Liao L, Martin J, Xu J. Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype. Int J Biol Sci. 2015;11:1056-72 pubmed 出版商
  12. Tien J, Liao L, Liu Y, Liu Z, Lee D, Wang F, et al. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. Int J Biol Sci. 2014;10:1116-27 pubmed 出版商
  13. Wagner M, Koslowski M, Paret C, Schmidt M, Tureci O, Sahin U. NCOA3 is a selective co-activator of estrogen receptor ?-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC Cancer. 2013;13:570 pubmed 出版商
  14. Kyathanahalli C, Marks J, Nye K, Lao B, Albrecht E, Aberdeen G, et al. Cross-species withdrawal of MCL1 facilitates postpartum uterine involution in both the mouse and baboon. Endocrinology. 2013;154:4873-84 pubmed 出版商
  15. Ory V, Tassi E, Cavalli L, Sharif G, Saenz F, Baker T, et al. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ. Oncogene. 2014;33:3033-42 pubmed 出版商